Diabetologia
Diabetologia
0012-186X
1432-0428
Springer-Verlag
Berlin/Heidelberg


2292420
18297259
950
10.1007/s00125-008-0950-y
Article


Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial

Praet
S. F. E.

Stephan.Praet@BW.unimaas.nl

1
6

van Rooij
E. S. J.

2

Wijtvliet
A.

1

Boonman-de Winter
L. J. M.

3

Enneking
Th.

4

Kuipers
H.

1

Stehouwer
C. D. A.

5

van Loon
L. J. C.

1

1
Department of Human Movement Sciences, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, Maastricht, the Netherlands 
2
Department of Clinical Health Psychology, Tilburg University, Tilburg, the Netherlands 
3
Department of Epidemiology and Contract Research, Stichting Huisartsen Laboratorium, Etten-Leur, the Netherlands 
4
Primary Healthcare Centre ‘De Keen’, Etten-Leur, the Netherlands 
5
Department of Internal Medicine, Academic Hospital Maastricht, Maastricht, the Netherlands 
6
Department of Human Movement Sciences, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands 

23
2
2008

5
2008

51
5
736
746
28
8
2007

14
1
2008


© The Author(s) 2008

Aims/hypothesis
Structured exercise is considered a cornerstone in type 2 diabetes treatment. However, adherence to combined resistance and endurance type exercise or medical fitness intervention programmes is generally poor. Group-based brisk walking may represent an attractive alternative, but its long-term efficacy as compared with an individualised approach such as medical fitness intervention programmes is unknown. We compared the clinical benefits of a 12-month exercise intervention programme consisting of either brisk walking or a medical fitness programme in type 2 diabetes patients.

Methods
n
n
1c
 values at 12 months. Secondary outcomes were differences in changes in blood pressure, plasma lipid concentrations, insulin sensitivity, body composition, physical fitness, programme adherence rate and health-related quality of life.

Results
After 12 months, 18 brisk walking and 19 medical fitness participants were still actively participating. In both programmes, 50 and 25% of the dropout was attributed to overuse injuries and lack of motivation, respectively. Intention-to-treat analyses showed no important differences between brisk walking and medical fitness programme in primary or secondary outcome variables.

Conclusions/interpretation
The prescription of group-based brisk walking represents an equally effective intervention to modulate glycaemic control and cardiovascular risk profile in type 2 diabetes patients when compared with more individualised medical fitness programmes. Future exercise intervention programmes should anticipate the high attrition rate due to overuse injuries and motivation problems.

Electronic supplementary material
The online version of this article (doi:10.1007/s00125-008-0950-y) contains supplementary material, which is available to authorised users.


Keywords
Blood pressure
Exercise
Hyperglycaemia
Lipid metabolism
Physical fitness
Randomised controlled clinical trial
Type 2 diabetes mellitus

issue-copyright-statement
© Springer-Verlag 2008




Introduction
1
2
5
6
7
3
5
7
9
10
17
11
18
20
6
21
22
3
23
], it is conceivable that the long-term efficacy of a medical fitness programme is greater than that of a brisk walking programme.
n
1c
3
23
1c
 than brisk walking.

Methods
Participants
24
25
26
n
n
1
1
Fig. 1
Study flow diagram



Table 1
Participants’ baseline characteristics

Characteristic
n
 = 92)
n
 = 49)
n
 = 43)


Age (years)
60 ± 9
61 ± 9
59 ± 9

n
)
47/45
27/22
20/23

Duration of diabetes (years)
5 ± 5
5 ± 4
5 ± 5

BW (kg)
94.3 ± 18.4
94.1 ± 18.1
94.5 ± 19.0

2
)
32.3 ± 5.5
32.1 ± 5.2
32.5 ± 6.0

W
max
 (W)
156 ± 47
155 ± 49
157 ± 45

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{{\text{2peak}}} $$\end{document}

 (l/min)
2.1 ± 0.6
2.1 ± 0.6
2.1 ± 0.6

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{{\text{2peak}}} $$\end{document}


82 ± 11
82 ± 10
83 ± 11

Participants treated with:

n
)
11
5
6

n
)

  Total
81
44
37

  Metformin
43
24
19

  Sulfonylurea
25
13
12

  Thiazolidinedione
10
4
6

  Insulin
13
6
7

n
)

  Total
59
32
27

  ACEI/ARB
39
20
19

  Beta-blocker
17
7
10

  Diuretic
19
10
9

  Calcium-channel blocker
9
5
4

  Other
3
1
2

n
)

  Total
54
30
24

  Statin
53
29
24

  Fibrate
1
1
0

  Other
0
0
0



n
 (number of participants) or means ± SD.
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{{\text{2peak}}} $$\end{document}

W
max
30
].
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{{\text{2peak}}} $$\end{document}

31
].
ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; BW, body weight




Exercise intervention
Overview
27
].
Brisk walking programme
1
.
Medical fitness programme
1
.
Energy expenditure and monitoring blood glucose
28
29
−1
−1
. Given the participants’ bodyweights, the exercise interventions should be regarded as moderate intensity. Participants were provided with blood glucose monitor systems and test strips (A. Menarini Diagnostics, Valkenswaard, the Netherlands) and during the first month of brisk walking or medical fitness were advised to assess capillary blood glucose levels ∼30 min before and after exercise. Patients were instructed to report recurrent hypoglycaemic events to their diabetes nurse educator or general practitioner. For logistic reasons no systematic enquiries on mild hypoglycaemic events were performed.
Financial cost of the intervention programmes
 Direct yearly costs for the individualised medical fitness programme were Euro 853 per participant and consisted of an ECG-stress test, supervision and consultations by a physical therapist, and the use of fitness centre facilities. The direct costs of the group-based brisk walking programme averaged Euro 396 per participant. Costs consisted of an ECG-stress test, supervision and consultation by a physical therapist, and a brisk walking membership fee. Other healthcare-related costs were not assessed.

Outcome variables
Resting heart rate and blood pressure
 Resting heart rate and blood pressure were determined in a supine position before and at 6 and 12 months after initiating the exercise programme. Heart rate was stored and averaged through a heart rate monitoring system (CO2ntrol; Tildesign, Zeewolde, the Netherlands). Average systolic and diastolic blood pressure were determined (HEM-907; Omron Healthcare, Hoofddorp, the Netherlands) from five successive measurements.
Physical fitness
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{2{\text{peak}}} $$\end{document}

W
max
30
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{2{\text{peak}}} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{2{\text{peak}}} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{2{\text{peak}}} $$\end{document}

31
].
Blood analyses
1c
g
32
33
1c
, 3 ml blood samples were collected and analysed by high-performance liquid chromatography (HA8160 Menarini; A. Menarini Diagnostics, Florence, Italy).

Quality-of-life assessment
34
35
] before and after 12 months of exercise intervention.

Statistical analyses
1c
α
36
t
χ
2
U
 tests were used to test whether long-term changes observed in brisk walking differed from those seen in the medical fitness programme. Significance was set at the 0.05 level of confidence. Pearson’s correlation calculation was used to test for linear relationships between long-term changes in dependent variables. All statistical calculations were performed using SPSS 10.1 (SPSS, Chicago, IL, USA).


Results
Characteristics of the study population
1
).

Programme adherence, follow-up and adverse events
p
2
p
2
1
2
p
Table 2
Adverse medical events

Events
n
 = 49)
n
 = 43)


Adverse events related to exercise intervention
15
12

 Shoulder pain/chronic tendinopathy of rotator cuff
0
1

 (Aggravation of) low back pain
2
2

 Aggravation of pre-existing osteoarthritis in hip or knee joint
6
4

 Shin splints/lower leg pain
1
0

 Chronic tendinopathy of Achilles tendon/plantar fascia
3
1

 Other/generalised musculoskeletal discomfort
3
3

Adverse events not related to exercise intervention
4
6

a

3
3

b

1
3

Participants with adverse event resulting in withdrawal
19
17



Data are number of participating diabetes patients that experienced an adverse event throughout the 12 months follow-up period
a
n
n
n
n
n
n
 = 1, did not result in withdrawal from study).
b
n
n
n
n
 = 1




Glycaemic control
1c
p
3
n
n
1c
p
1c
p
3
Table 3
Changes in diabetes outcome (ITT analysis)

Variable
Change from baseline to 12 months

Mean ± SD
n

Mean ± SD
n

Difference
95% CI
p
 Value


1c
 (%)

 Total
7.13 ± 1.36
92
6.99 ± 1.26
71
 

 

 Brisk walking group
7.18 ± 1.42
49
7.08 ± 1.37
38
 
 
 

 Medical fitness group
7.08 ± 1.29
43
6.89 ± 1.13
33
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.14
−0.39, 0.03
0.153

  Intragroup comparison brisk walking
 
 
 
 
−0.11
−0.51, 0.15
0.464

  Intragroup comparison medical fitness
 
 
 
 
−0.18
−0.45, 0.09
0.176

 Brisk walking vs medical fitness
 
 
 
 
0.00
−0.42, 0.43
0.985

2
)

 Total
32.3 ± 5.5
92
31.8 ± 5.4
89
 
 
 

 Brisk walking group
32.1 ± 5.2
49
31.9 ± 5.0
48
 
 
 

 Medical fitness group
32.5 ± 6.0
43
31.7 ± 5.9
41
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.5
−1.1, 0.1
0.108

  Intragroup comparison brisk walking
 
 
 
 
−0.2
−0.6, 0.3
0.471

  Intragroup comparison medical fitness
 
 
 
 
−0.8
−2.0, 0.3
0.152

 Brisk walking vs medical fitness
 
 
 
 
0.7
−0.5, 1.9
0.237

Fasting plasma glucose (mmol/l)

 Total
8.44 ± 2.81
92
8.21 ± 2.37
71
 
 
 

 Brisk walking group
8.64 ± 2.83
49
8.33 ± 2.64
38
 
 
 

 Medical fitness group
8.21 ± 2.80
43
8.06 ± 2.05
33
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.23
−0.72, 0.25
0.345

  Intragroup comparison brisk walking
 
 
 
 
−0.31
−0.96, 0.34
0.344

  Intragroup comparison medical fitness
 
 
 
 
−0.15
−0.91, 0.61
0.699

 Brisk walking vs. medical fitness
 
 
 
 
−0.16
−1.14, 0.82
0.744

a


 Total
5.55 ± 3.68
68
5.60 ± 3.38
54
 
 
 

 Brisk walking group
5.86 ± 3.56
37
5.75 ± 3.20
30
 
 
 

 Medical fitness group
5.19 ± 3.58
31
5.43 ± 3.64
24
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
0.05
−0.50, 0.62
0.833

  Intragroup comparison brisk walking
 
 
 
 
−0.12
−1.11, 0.85
0.794

  Intragroup comparison medical fitness
 
 
 
 
0.24
−0.19, 0.74
0.241

 Brisk walking vs medical fitness
 
 
 
 
−0.40
−1.52, 0.72
0.479

Resting heart rate (bpm)

 Total
73.4 ± 11.8
91
69.6 ± 13.9
77
 
 
 

 Brisk walking group
72.6 ± 11.8
48
68.3 ± 15.0
41
 
 
 

 Medical fitness group
74.4 ± 11.8
43
71.0 ± 12.4
36
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−3.9
−5.9, −1.8
0.000

  Intragroup comparison brisk walking
 
 
 
 
−4.3
−7.4, −1.1
0.009

  Intragroup comparison medical fitness
 
 
 
 
−3.4
−5.9, −0.9
0.010

 Brisk walking vs medical fitness
 
 
 
 
−0.9
−4.9, 3.2
0.678

Systolic blood pressure (mmHg)

 Total
148.5 ± 18.1
91
137.5 ± 15.5
77
 
 
 

 Brisk walking group
150.3 ± 18.9
48
138.9 ± 16.3
41
 
 
 

 Medical fitness group
146.3 ± 17.1
43
135.9 ± 14.6
36
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−10.9
−14.0, −7.8
0.000

  Intragroup comparison brisk walking
 
 
 
 
−11.4
−15.9, −6.8
0.000

  Intragroup comparison medical fitness
 
 
 
 
−10.4
−14.7, 6.2
0.000

 Brisk walking vs medical fitness
 
 
 
 
−0.9
−7.1, 5.3)
0.768

Diastolic blood pressure (mmHg)

 Total
81.9 ± 10.6
91
76.6 ± 8.3
77
 
 
 

 Brisk walking group
81.3 ± 10.8
48
75.9 ± 8.8
41
 
 
 

 Medical fitness group
82.6 ± 10.4
43
77.4 ± 7.7
36
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−5.3
−7.1, −3.6
0.000

  Intragroup comparison brisk walking
 
 
 
 
−5.4
−7.8, 2.9
0.000

  Intragroup comparison medical fitness
 
 
 
 
−5.2
−7.8, −2.7
0.000

 Brisk walking vs medical fitness
 
 
 
 
−0.1
−3.6, 3.4
0.949

Total cholesterol level (mmol/l)

 Total
4.70 ± 0.86
88
4.53 ± 0.94
65
 
 
 

 Brisk walking group
4.83 ± 0.89
47
4.61 ± 0.92
35
 
 
 

 Medical fitness group
4.54 ± 0.12
41
4.44 ± 0.96
30
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.16
−0.32, −0.01
0.035

  Intragroup comparison brisk walking
 
 
 
 
−0.22
−0.45, 0.01
0.064

  Intragroup comparison medical fitness
 
 
 
 
−0.10
−0.30, 0.10
0.307

 Brisk walking vs medical fitness
 
 
 
 
−0.12
−0.42, 0.19
0.453

LDL-cholesterol level (mmol/l)

 Total
2.83 ± 0.76
88
2.70 ± 0.79
64
 
 
 

 Brisk walking group
2.90 ± 0.82
47
2.72 ± 0.85
35
 
 
 

 Medical fitness group
2.74 ± 0.69
41
2.68 ± 0.72
29
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.12
−0.26, 0.01
0.070

  Intragroup comparison brisk walking
 
 
 
 
−0.18
−0.38, 0.02
0.080

  Intragroup comparison medical fitness
 
 
 
 
−0.06
–0.25, 0.12
0.493

 Brisk walking vs medical fitness
 
 
 
 
−0.11
−0.38, 0.16
0.401

HDL-cholesterol level (mmol/l)

 Total
1.09 ± 0.28
88
1.10 ± 0.29
65
 
 
 

 Brisk walking group
1.10 ± 0.23
47
1.09 ± 0.26
35
 
 
 

 Medical fitness group
1.07 ± 0.33
41
1.11 ± 0.32
30
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.01
–0.02, 0.04
0.570

  Intragroup comparison brisk walking
 
 
 
 
−0.01
−0.06, 0.04
0.629

  Intragroup comparison medical fitness
 
 
 
 
0.03
−0.01, 0.08
0.129

 Brisk walking vs medical fitness
 
 
 
 
−0.05
−0.12, 0.02
0.172

Triacylglycerol level (mmol/l)

 Total
1.88 ± 0.99
88
1.79 ± 0.91
64
 
 
 

 Brisk walking group
2.00 ± 1.08
47
1.94 ± 0.98
35
 
 
 

 Medical fitness group
1.74 ± 0.88
41
1.61 ± 0.79
29
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.09
−0.25, 0.06
0.239

  Intragroup comparison brisk walking
 
 
 
 
−0.06
−0.33, 0.17
0.646

  Intragroup comparison medical fitness
 
 
 
 
−0.13
−0.27, 0.06
0.120

 Brisk walking vs medical fitness
 
 
 
 
−0.02
−0.29, 0.33
0.892

RAND-36 (score 0–100 scale)

 Total
71 ± 15
89
70 ± 15
58
 
 
 

 Brisk walking group
69 ± 15
46
68 ± 15
31
 
 
 

 Medical fitness group
73 ± 15
43
71 ± 14
27
 
 
 

 Intragroup comparisons
 
 
 
 
 
 
 

  Intragroup comparison total
 
 
 
 
−0.6
−2.4, 1.2
0.503

  Intragroup comparison brisk walking
 
 
 
 
0.1
–2.7, 2.8
0.969

  Intragroup comparison medical fitness
 
 
 
 
−1.4
−3.8, 1.1
0.261

 Brisk walking vs medical fitness
 
 
 
 
1.4
−2.2, 5.0
0.438



n
a
n
 = 13) were excluded




Resting heart rate and blood pressure
p
3
n
n
p
p
3
).

Blood lipid profile
3
n
n
p
 = 0.17) in the medical fitness compared with the brisk walking group.

Body composition and workload capacity
3
p
p
p
p
W
max
p
1c
W
max
R
p
n
R
p
n
 = 45).

Quality of life assessment
p
3
).


Discussion
37
15
19
3
38
39
23
40
42
43
44
45
21
46
] might help to further improve programme adherence. Nevertheless, more long-term, tailored exercise intervention studies are warranted to further define the most effective and feasible exercise interventional strategy.
1c
3
7
27
47
49
3
). Although reliable assessment of actual drug use was not possible in the present study, the improvements in blood pressure occurred independently of changes in the prescription of antihypertensive medication. However, the lack of a non-exercise control group in the present study makes it impossible to speculate on cause and effect, since changes in blood pressure from baseline might also, or at least partly, be explained by the Hawthorne effect, for example, or by familiarisation with blood pressure measurement protocols. Nevertheless, our data suggest that the structured application of group-based brisk walking and supervised medical fitness programmes tends to have a similar impact on cardiovascular risk profile.
In conclusion, the prescription of group-based brisk walking represents an equally effective interventional strategy to modulate glycaemic control and cardiovascular risk profile in type 2 diabetes patients compared with a more individualised medical fitness programme. General deconditioning, musculoskeletal overuse injuries and lack of motivation limit the benefits of long-term exercise intervention as an add-on to a comprehensive diabetes care programme. Future diabetes exercise intervention programmes in primary healthcare settings should consider diabetes-related co-morbidities and patient motivation as important factors, which determine both long-term programme adherence and the associated clinical benefits.

Electronic supplementary material
Below is the link to the electronic supplementary material.

Table 1
Exercise programme (PDF 60.7 KB)


Table 2
1c
) and active programme participation (PDF 69.9 KB)


Table 3
Changes in diabetes outcome in long-term active participants (PDF 160 KB)





Acknowledgements
This study was funded by a Dutch Healthcare Innovation Foundation research grant from ‘OZ-zorgverzekeringen’ healthcare insurance company. The salary of S. F. Praet was funded by a research grant from the Dutch Ministry of Health, Welfare and Sports. The authors thank all participating participants, as well as M. van Hoogstraten and all certified trainers from AVR Achilles and BodyActive for participating in and supervising the exercise programmes, respectively. A. Menarini Diagnostics Benelux supplied our patients with free blood glucose monitoring systems and test strips. RSscan International provided our participants with free protective footwear and customised insoles. We are also extremely grateful to S. Konings, J. Lambregts, H. Wierema, M. Schaerlaeckens, A. van der Smissen, R. Lendfers, R. Swens, R. van Hal, S. van der Poel, R. Masseurs, H. Bronts, P. Litjens, S. van Rooij and L. van den Meijdenberg for their input and logistic support.
Duality of interest
 The authors declare that there is no duality of interest associated with this study.
Open Access
 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

References
1.
Berger
M


Muscular work in the therapy of diabetes mellitus
Fortschr Med
1976
94
1553
1557

976928


2.
Knowler
WC

Barrett-Connor
E

Fowler
SE



Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
N Engl J Med
2002
346
393
403
10.1056/NEJMoa012512

11832527


3.
Snowling
NJ

Hopkins
WG


Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis
Diabetes Care
2006
29
2518
2527
10.2337/dc06-1317

17065697


4.
Thomas
DE

Elliott
EJ

Naughton
GA


Exercise for type 2 diabetes mellitus
Cochrane Database Syst Rev
2006
3
CD002968

16855995


5.
Conn
VS

Hafdahl
AR

Mehr
DR

Lemaster
JW

Brown
SA

Nielsen
PJ


Metabolic effects of interventions to increase exercise in adults with type 2 diabetes
Diabetologia
2007
50
913
921
10.1007/s00125-007-0625-0

17342472


6.
Loreto
C

Fanelli
C

Lucidi
P



Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes
Diabetes Care
2005
28
1295
1302
10.2337/diacare.28.6.1295

15920042


7.
Boule
NG

Kenny
GP

Haddad
E

Wells
GA

Sigal
RJ


Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus
Diabetologia
2003
46
1071
1081
10.1007/s00125-003-1160-2

12856082


8.
Nielsen
PJ

Hafdahl
AR

Conn
VS

Lemaster
JW

Brown
SA


Meta-analysis of the effect of exercise interventions on fitness outcomes among adults with type 1 and type 2 diabetes
Diabetes Res Clin Pract
2006
74
111
120
10.1016/j.diabres.2006.03.033

16735074


9.
Boule
NG

Haddad
E

Kenny
GP

Wells
GA

Sigal
RJ


Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials
Jama
2001
286
1218
1227
10.1001/jama.286.10.1218

11559268


10.
Burns
N

Finucane
FM

Hatunic
M



Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training
Diabetologia
2007
50
1500
1508
10.1007/s00125-007-0655-7

17393133


11.
Dunstan
DW

Vulikh
E

Owen
N

Jolley
D

Shaw
J

Zimmet
P


Community center-based resistance training for the maintenance of glycemic control in adults with type 2 diabetes
Diabetes Care
2006
29
2586
2591
10.2337/dc06-1310

17130189


12.
Tokmakidis
SP

Zois
CE

Volaklis
KA

Kotsa
K

Touvra
AM


The effects of a combined strength and aerobic exercise program on glucose control and insulin action in women with type 2 diabetes
Eur J Appl Physiol
2004
92
437
442
10.1007/s00421-004-1174-6

15232701


13.
McGavock
J

Mandic
S

Lewanczuk
R



Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus
Cardiovasc Diabetol
2004
3
3
10.1186/1475-2840-3-3

15023235


14.
Alam
S

Stolinski
M

Pentecost
C



The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes
J Clin Endocrinol Metab
2004
89
688
694
10.1210/jc.2003-031036

14764782


15.
Loimaala
A

Huikuri
HV

Koobi
T

Rinne
M

Nenonen
A

Vuori
I


Exercise training improves baroreflex sensitivity in type 2 diabetes
Diabetes
2003
52
1837
1842
10.2337/diabetes.52.7.1837

12829654


16.
Castaneda
C

Layne
JE

Munoz-Orians
L



A randomised controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes
Diabetes Care
2002
25
2335
2341
10.2337/diacare.25.12.2335

12453982


17.
Ligtenberg
PC

Hoekstra
JB

Bol
E

Zonderland
ML

Erkelens
DW


Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients
Clin Sci (Lond)
1997
93
127
135

9301427


18.
Schneider
SH

Khachadurian
AK

Amorosa
LF

Clemow
L

Ruderman
NB


Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus
Diabetes Care
1992
15
1800
1810
10.2337/diacare.15.11.1800

1468318


19.
Balducci
S

Leonetti
F

Mario
U

Fallucca
F


Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients?
Diabetes Care
2004
27
841
842
10.2337/diacare.27.3.841

14988317


20.
Hanefeld
M

Fischer
S

Schmechel
H



Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM
Diabetes Care
1991
14
308
317
10.2337/diacare.14.4.308

2060433


21.
Tudor-Locke
C

Bell
RC

Myers
AM



Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes
Int J Obes Relat Metab Disord
2004
28
113
119
10.1038/sj.ijo.0802485

14569279


22.
Fritz
T

Rosenqvist
U


Walking for exercise - immediate effect on blood glucose levels in type 2 diabetes
Scand J Prim Health Care
2001
19
31
33

11303544


23.
Sigal
RJ

Kenny
GP

Boule
NG



Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomised trial
Ann Intern Med
2007
147
357
369

17876019


24.
Bouma
M

Rutten
GE

Grauw
WJ

Wiersma
T

Goudswaard
AN


[Summary of the practice guideline ‘Diabetes mellitus type 2’ (second revision) from the Dutch College of General Practitioners]
Ned Tijdschr Geneeskd
2006
150
2251
2256

17076359


25.
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus
1999
Geneva
World Health Organization

World Health Organization Expert Committee (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva 

26.
Zhang
YY

Johnson
MC

Chow
N

Wasserman
K


Effect of exercise testing protocol on parameters of aerobic function
Med Sci Sports Exerc
1991
23
625
630

2072842


27.
Sigal
RJ

Kenny
GP

Wasserman
DH

Castaneda-Sceppa
C

White
RD


Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association
Diabetes Care
2006
29
1433
1438
10.2337/dc06-9910

16732040


28.
Byrne
NM

Hills
AP

Hunter
GR

Weinsier
RL

Schutz
Y


Metabolic equivalent: one size does not fit all
J Appl Physiol
2005
99
1112
1119
10.1152/japplphysiol.00023.2004

15831804


29.
Phillips
WT

Ziuraitis
JR


Energy cost of single-set resistance training in older adults
J Strength Cond Res
2004
18
606
609
10.1519/1533-4287(2004)18<606:ECOSRT>2.0.CO;2

15320686


30.
Storer
TW

Davis
JA

Caiozzo
VJ


\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot V{\text{O}}_{{\text{2max}}} $$\end{document}

 in cycle ergometry
Med Sci Sports Exerc
1990
22
704
712
10.1249/00005768-199010000-00024

2233211


31.
Fairbarn
MS

Blackie
SP

McElvaney
NG

Wiggs
BR

Pare
PD

Pardy
RL


Prediction of heart rate and oxygen uptake during incremental and maximal exercise in healthy adults
Chest
1994
105
1365
1369
10.1378/chest.105.5.1365

8181321


32.
Matthews
DR

Hosker
JP

Rudenski
AS

Naylor
BA

Treacher
DF

Turner
RC


Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
Diabetologia
1985
28
412
419
10.1007/BF00280883

3899825


33.
Katsuki
A

Sumida
Y

Gabazza
EC



Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes
Diabetes Care
2001
24
362
365
10.2337/diacare.24.2.362

11213893


34.
Hays
RD

Sherbourne
CD

Mazel
RM


The RAND 36-item health survey 1.0
Health Econ
1993
2
217
227
10.1002/hec.4730020305

8275167


35.
VanderZee
KI

Sanderman
R

Heyink
JW

Haes
H


Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status
Int J Behav Med
1996
3
104
122
10.1207/s15327558ijbm0302_2

16250758


36.
Unnebrink
K

Windeler
J


Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases
Stat Med
2001
20
3931
3946
10.1002/sim.1149

11782044


37.
Kirk
A

Mutrie
N

MacIntyre
P

Fisher
M


Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes
Diabetologia
2004
47
821
832
10.1007/s00125-004-1396-5

15138687


38.
Haus
JM

Carrithers
JA

Trappe
SW

Trappe
TA


Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle
J Appl Physiol
2007
103
2068
2076
10.1152/japplphysiol.00670.2007

17901242


39.
Kjaer
M


Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading
Physiol Rev
2004
84
649
698
10.1152/physrev.00031.2003

15044685


40.
Must
A

Spadano
J

Coakley
EH

Field
AE

Colditz
G

Dietz
WH


The disease burden associated with overweight and obesity
Jama
1999
282
1523
1529
10.1001/jama.282.16.1523

10546691


41.
Sturmer
T

Brenner
H

Brenner
RE

Gunther
KP


Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study
Scand J Rheumatol
2001
30
169
171
10.1080/030097401300162969

11469529


42.
Andersen
H

Nielsen
S

Mogensen
CE

Jakobsen
J


Muscle strength in type 2 diabetes
Diabetes
2004
53
1543
1548
10.2337/diabetes.53.6.1543

15161759


43.
Willey
KA

Singh
MA


Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights
Diabetes Care
2003
26
1580
1588
10.2337/diacare.26.5.1580

12716822


44.
Feyter
HM

Praet
SF

Broek
NM



Exercise training improves glycemic control in long-standing, insulin-treated type 2 diabetes patients
Diabetes Care
2007
30
2511
2513
10.2337/dc07-0183

17626892


45.
West
DS

DiLillo
V

Bursac
Z

Gore
SA

Greene
PG


Motivational interviewing improves weight loss in women with type 2 diabetes
Diabetes Care
2007
30
1081
1087
10.2337/dc06-1966

17337504


46.
Kirk
A

Feo
P


Strategies to enhance compliance to physical activity for patients with insulin resistance
Appl Physiol Nutr Metab
2007
32
549
556
10.1139/H07-023

17510696


47.
Ivy
JL


Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus
Sports Med
1997
24
321
336

9368278


48.
Brandon
LJ

Gaasch
DA

Boyette
LW

Lloyd
AM


Effects of long-term resistive training on mobility and strength in older adults with diabetes
J Gerontol A Biol Sci Med Sci
2003
58
740
745

12902533


49.
Pedersen
BK

Saltin
B


Evidence for prescribing exercise as therapy in chronic disease
Scand J Med Sci Sports
2006
16
Suppl 1
3
63
10.1111/j.1600-0838.2006.00520.x

16451303



Abbreviations
bpm
beats per min


HOMA
homeostasis model assessment


ITT
intention-to-treat


\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\mathop {V{\text{O}}}\limits^ \cdot _{2{\text{peak}}} $$\end{document}


peak oxygen uptake capacity


W
max

maximum workload capacity




Electronic supplementary material

The online version of this article (doi:10.1007/s00125-008-0950-y) contains supplementary material, which is available to authorised users.




